Anja Fleischmann
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Rapid and profound treatment response of difficult-to-treat rheumatoid arthritis to CD19 CAR T-cell therapy.
Journal: EULAR rheumatology open
Published: August 01, 2026
BCMA-directed therapy with cizutamig induces rapid improvement in long-standing systemic sclerosis-associated interstitial lung disease.
Journal: Rheumatology (Oxford, England)
Published: June 23, 2026
Teclistamab induces rapid clinical response and deep tissue depletion in refractory systemic sclerosis-a case series.
Journal: Annals of the rheumatic diseases
Published: January 19, 2026
Teclistamab-induced rapid remission in refractory Anti-Jo-1 Antisynthetase Syndrome.
Journal: Annals of the rheumatic diseases
Published: September 07, 2025
Targeting autoimmunity with CD19-CAR T-cell therapy: efficacy and seroconversion in diffuse systemic sclerosis and rheumatoid arthritis.
Journal: Rheumatology (Oxford, England)
Published: December 11, 2024
Teclistamab in relapsed systemic sclerosis after autologous haematopoietic stem cell transplantation.
Journal: Annals of the rheumatic diseases
Published: November 25, 2024
Anti-CD19 CAR T cell therapy induces antibody seroconversion and complete B cell depletion in the bone marrow of a therapy-refractory patient with ANCA-associated vasculitis.
Journal: Annals of the rheumatic diseases
Published: September 17, 2024
Degeneration of Lumbar Intervertebral Discs: Characterization of Anulus Fibrosus Tissue and Cells of Different Degeneration Grades.
Journal: International journal of molecular sciences
Published: February 28, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026